Literature DB >> 17702500

Intravascular large B-cell lymphoma presenting with neurological syndromes: clinicopathologic study.

A Ortega Aznar1, M A Montero, R Rovira, F Romero Vidal.   

Abstract

Intravascular lymphoma or intravascular lymphomatosis (IVL) is an uncommon extranodal lymphoma, which gives rise to exclusively intravascular tumor growth. In 1/3 of the reported cases the disease debuts with involvement of the nervous system, which is particularly susceptible. Over the clinical course of the disease, 2/3 of the patients will present neurological symptoms. Owing to its characteristic growth pattern, IVL can give rise to very different central or peripheral nervous system neurological syndromes. Not infrequently a single patient will present more than one neurological syndrome. Moreover, the specificity of the neurological tests is low. All these factors explain the difficulties involved in diagnosing this entity and the fact that in most cases the diagnosis is established on autopsy study. This article presents the clinical, biological, radiological and post-mortem neuropathological findings in an immunocompetent patient with IVL. The onset was a cauda equina syndrome and showed multiple and varied neurological manifestations during the course of the disease, which progressed in the months before death. Spinal cord biopsy performed in life did not provide diagnostic findings because the vessels showed no neoplastic involvement. Immunohistochemical findings demonstrated large B-cell lymphoma. A review of the neurological features described in previously published cases of IVL is provided.

Entities:  

Mesh:

Year:  2007        PMID: 17702500     DOI: 10.5414/npp26180

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

1.  Intravascular lymphoma: an unusual cause of rapid cognitive decline and the role of brain biopsy.

Authors:  Sujata Chaturvedi; Ishita Pant; Suman Kushwaha; Deepak Kumar Jha
Journal:  BMJ Case Rep       Date:  2014-08-21

Review 2.  Subacute cognitive disorders as initial presentation of intravascular lymphoma: a case report and review of literature.

Authors:  Manuela Gioulis; Giampaolo Ben; Paolo Iuzzolino; Francesca De Biasi; Corrado Marchini; Sandro Zambito Marsala
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

3.  A 16-year old male with cortical blindness and focal motor seizures.

Authors:  S M Katrak; A Mahadevan; Arun B Taly; S Sinha; S K Shankar
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

4.  Status epilepticus as the initial presentation of intravascular lymphoma.

Authors:  Akiyuki Hiraga; Daisuke Ozaki; Ikuo Kamitsukasa; Nobuyuki Araki; Kimihito Arai
Journal:  Case Rep Neurol       Date:  2012-06-19

5.  Insufficiency of positron emission tomography and magnetic resonance spectroscopy in the diagnosis of intravascular lymphoma of the central nervous system.

Authors:  Nobuyuki Kawai; Masaki Okada; Reiji Haba; Yuka Yamamoto; Takashi Tamiya
Journal:  Case Rep Oncol       Date:  2012-07-03

6.  Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients.

Authors:  Ekokobe Fonkem; Samantha Dayawansa; Edana Stroberg; Edwin Lok; Paul C Bricker; Batool Kirmani; Eric T Wong; Jason H Huang
Journal:  BMC Neurol       Date:  2016-01-16       Impact factor: 2.474

7.  Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy.

Authors:  Sied Kebir; Klaus Kuchelmeister; Pitt Niehusmann; Michael Nelles; Young Kim; Sharmilan Thanendrarajan; Niklas Schäfer; Moritz Stuplich; Frederic Mack; Björn Scheffler; Horst Urbach; Martin Glas; Ulrich Herrlinger
Journal:  Exp Hematol Oncol       Date:  2012-12-05

8.  Intravascular large B-cell lymphoma presenting as rapidly progressive dementia and stroke: A case report.

Authors:  Ming Wu; Yinyao Lin; Xuehong Huang; Bingjun Zhang
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.